期刊文献+

左归丸及右归丸创方思想的历史考察 被引量:20

Historical Investigation of the Creating Thought of Zuogui Pill(左归丸) and Yougui Pill(右归丸)
原文传递
导出
摘要 左归丸、右归丸是张介宾治疗肾脏阴阳亏损的重方,既往对二方的组方讨论多局限于君、臣、佐、使的配伍理论、药物功效及统计分析,至于二方如何创制的问题着墨不多。认为从张介宾医学思想的传承以及对药物的认知方面分析,左归丸、右归丸其实是张介宾取"六味之意",并依其真阴学说为核心,参以个人用药体悟而创制的新方。左归丸、右归丸在医方结构上具有同根的特点,用药之法也与《类经》和《景岳全书》中的记载相合,可视为张介宾将医理融于临证遣方的一种结果。 Zuogui Pill and Yougui Pill are the important prescriptions of ZHANG Jiebin in treating Yin and Yang deficiency of kidney. Previously, the discussions about the composition of these two prescriptions were mainly limited in the compatibility theory of monarch, minister, assistant and guide, as well as prescription effect and statistical analysis. However, how these two prescriptions were created is seldom mentioned. Analysis from the medical thought inheritance of ZHANG Jiebin and the cognition of drugs shows that actually Zuogui Pill and Yougui Pill are the new created prescriptions of ZHANG ]iebin, he quoted the meaning of "six flavors" (六味), and made his " true Yin" (真阴) theory as the core, combined with his individual medication knowledge and created them. Zuogui Pill and Yougui Pill share the same characteristics in the prescription structure, and the principles of drugs using are in consis- tency with "Lei Jing" (《类经》) and "Jingyue Quanshu" (《景岳全书》). These can be regarded as the result of ZHANG Jiebin's reconciliation of medical knowledge into clinical practice.
作者 周敏 方晓阳
出处 《中医杂志》 CSCD 北大核心 2015年第11期901-905,共5页 Journal of Traditional Chinese Medicine
基金 国家自然科学基金(11120005)
关键词 方剂史 张介宾 左归丸 右归丸 prescription history ZHANG Jiebin Zuogui Pill Yougui Pill
  • 相关文献

参考文献8

二级参考文献18

  • 1邢斌.论类方与类方证群相关[J].中医杂志,2005,46(7):483-485. 被引量:22
  • 2姚洁敏,邢斌,陈德兴.龙胆泻肝汤类方用药规律初探[J].上海中医药大学学报,2007,21(1):64-67. 被引量:12
  • 3冈田研吉,牧角和宏,小高修司.宋以前伤寒论考[M].日本东洋学术出版社,2007.
  • 4Graham JM, Ayati BP, Holstein SA, et al. The role of osteocytes in targeted bone remodeling: a mathematical model[J]. PLoS One, 2013,8 ( 5 ):63884.
  • 5Roux S. New treatment targets in osteoporosis[J]. Joint Bone Spine,2010,77(3) :222 - 228.
  • 6Sharma AR, Choi BS, Park JM, et al. Rspo 1 promotes osteoblast differentiation via Wnt signaling pathway[J]. Indian J Biochem Biophys, 2013,50 ( 1 ) : 19 - 25.
  • 7Voronkov A, Krauss S. Wnt/beta-catenin signaling and small molecule inhibitors[J]. Curr Pharm Des, 2013, 19 (4) : 634 - 664.
  • 8Cho HH,Kim YJ,Kim SJ,et al. Endogenous Wnt signa- ling promotes proliferation and suppresses osteogenic dif ferentiation in human adipose derived stromal cells[J]. Tissue Eng, 2006,12(1):111 - 121.
  • 9Qiu W, Andersen TE, Bollerslev J, et al. Patients with high bone mass phenotype exhibit enhanced osteoblas differentiation and inhibition of adipogenesis of human mesenehymal stem cells[J]. J Bone Miner Res, 2007,22 (11) :1720 - 1731.
  • 10Eijken M, Meijer IM,Westbroek l,et al. Wnt signaling acts and is regulated in a human osteoblast differentia- tion dependent manner[J]. J Cell Biochem, 2008, 104 (2) :568 - 579.

共引文献99

同被引文献271

引证文献20

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部